Key result
A left ventricular outflow tract gradient ≥30 mmHg was associated with a significantly lower rate of cardiac death compared to patients without a gradient (11% vs 28%, P=0.039).
Why the study?
Does a left ventricular outflow tract gradient increase death from a cardiac cause in patients with hypertrophic cardiomyopathy?
Cohort (n=125)
Does a left ventricular outflow tract gradient increase death from a cardiac cause in patients with hypertrophic cardiomyopathy?
In patients with hypertrophic cardiomyopathy, the presence of a left ventricular outflow tract gradient does not independently predict adverse prognosis, whereas decreased ejection fraction and raised pulmonary artery pressure are independent prognostic determinants.
Answers are grounded in this paper and cite their sources.
LVOT gradient ≥30 mmHg was associated with lower cardiac death in HCM; leaves open independent prognostic value and should not yet change risk stratification.
The relationship of left ventricular outflow tract gradient as well as of clinical, ECG and haemodynamic data to presenting features and prognosis was evaluated in 125 consecutive patients with hypertropic cardiomyopathy, 79 men and 46 women (mean age: 34 +/- 7 years) studied between January 1970 and December 1985. Most clinical, ECG and haemodynamic findings were similar in the 44 patients (35%) with a pressure gradient (greater than or equal to 30 mmHg) and in the 81 patients (65%) without. Those with obstruction had greater ECG voltage SV1 and RV5; however, higher grade ventricular arrhythmias were more common in patients without obstruction. During a mean follow-up period of 7.6 +/- 4.5 years (range 2-18 years), death from a cardiac cause occurred in 28 patients (21 died suddenly) and was significantly less common in patients with a pressure gradient than in those without (11% vs 28%, P = 0.039). Univariate analysis of survival curves showed that the most powerful predictors of a poor prognosis were ejection fraction P = 0.0001), mean pulmonary artery pressure (P = 0.0001), dyspnoea (P = 0.001), left ventricular end-diastolic pressure (P = 0.002), complex ventricular arrhythmias (P = 0.029) and severe mitral regurgitation (P = 0.037). Using multivariate analysis, a decreased ejection fraction (P = 0.006) and a raised mean pulmonary artery pressure (P = 0.022) were the only independent prognostic determinants. Thus, the presence of a left ventricular outflow tract gradient does not seem of adverse prognostic significance. Risk factor characterization in patients with hypertrophic cardiomyopathy may be improved by assessment of ventricular arrhythmias in the context of left ventricular function.
No takes yet. Share an insight, caveat, or question.
Romeo et al. (1990) conducted a cohort in Hypertrophic cardiomyopathy (n=125). Left ventricular outflow tract gradient (≥30 mmHg) vs. No left ventricular outflow tract gradient was evaluated on Death from a cardiac cause (p=0.039). A left ventricular outflow tract gradient ≥30 mmHg was associated with a significantly lower rate of cardiac death compared to patients without a gradient (11% vs 28%, P=0.039).
Synapse has enriched 10 related papers. Consider them for comparative context: